Clinical trial
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
NCT00392678 · Joslin Diabetes Center, Other · Completed
Key facts
| NCT number | NCT00392678 |
|---|---|
| Title | Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D) |
| Official title | Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate |
| Acronym | TINSAL-T2D |
| Lead sponsor | Joslin Diabetes Center, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | Salsalate, Placebo |
| Enrollment | 277 |
| Start date | Oct 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Dec 1, 2010 |
| First posted | Oct 26, 2006 |
| Last update posted | Apr 8, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: